Jul 31, 09:09
AnnouncementsArvind Remedies: Board recommends dividend
AnnouncementsArvind Remedies to consider dividend on May 29, 2014
AnnouncementsArvind Remedies postponed its May 06 board meeting
AnnouncementsArvind Remedies to consider dividend
100% of moneycontrol users recommend buying Arvind Remedies.
What's your call on Arvind Remedies today?
Read 5 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2807.40||-0.53||2939.80||2140.35||47,819.86|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Arvind Remedies is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 209.83 crore.The company has reported a standalone sales of Rs 274.32 crore and a Net Profit of Rs 10.63 crore for the quarter ended Mar 2014.
The company management includes B Arvind Shah - Managing Director & CEO, Chandra Ravindran - Whole Time Director, C M K Reddy - Director, R Raja Mohan - Director, V R Mehta - Director, Ankur Agarwal - Executive Director, Sudhir Chandra - Additional Director.
It is listed on the BSE with a BSE Code of 531823 and the NSE with an NSE Code of ARVINDREM.
Its Registered office is at 190, Poonamallee High Road , Chennai (Madras),Tamil Nadu - 600084.
Their Registrars are Cameo Corporate Services Ltd.